Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML
Sign Up to like & getrecommendations! Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-32306-4
Abstract: Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) are chronic myeloid clonal neoplasms. To date, the only potentially curative therapy for these disorders remains allogeneic hematopoietic progenitor cell transplantation (HCT), although patient eligibility is limited… read more here.
Keywords: mds cmml; target mds; cmml; therapeutic target ... See more keywords